Open access
Jul 2026
Targeting DYNC1I1 attenuates Parkinsonian neurodegeneration and α-synuclein accumulation in cellular and mouse models.
DYNC1I1-targeting interventions attenuated PD-related phenotypes in cellular and mouse models and were accompanied by improved autophagic-lysosomal marker profiles and increased PI3K/AKT phosphorylation.
Yuyu Li, Li Xu, Hui Sun et al.
· Brain Research Bulletin · 0 citations